“Autologous Haemopoietic Stem-Cell Transplantation Followed By Allogeneic Or Autologous Haemopoietic Stem-Cell Transplantation In Patients With Multiple Myeloma (Bmt Ctn 0102): A Phase 3 Biological Assignment Trial.”. Lancet Oncol 12 (13). Lancet Oncol: 1195-203. doi:10.1016/S1470-2045(11)70243-1.
. 2011. “Autologous Transplantation, Consolidation, And Maintenance Therapy In Multiple Myeloma: Results Of The Bmt Ctn 0702 Trial.”. J Clin Oncol 37 (7). J Clin Oncol: 589-597. doi:10.1200/JCO.18.00685.
. 2019. “Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, And Cyclophosphamide; Tacrolimus, Methotrexate, And Bortezomib; Or Tacrolimus, Methotrexate, And Maraviroc) Versus Tacrolimus And Methotrexate For Prevention Of Graft-Versus-Host Disease With”. Lancet Haematol 6 (3). Lancet Haematol: e132-e143. doi:10.1016/S2352-3026(18)30221-7.
. 2019.